MedTrace Logo

Safety and Efficacy of Adipose Derived Stem Cells for Non-Ischemic Congestive Heart Failure

NCT01502501 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2017-07-21

No results posted yet for this study

Summary

The intent of this clinical study is to answer the questions:

1. Is the proposed treatment safe
2. Is treatment effective in improving the disease pathology of patients with Heart Disease as assessed by a series of measurements indicating improvement, stability, or degradation of a patient's cardiovascular function and exercise capacity?

Conditions

  • Non-Ischemic Congestive Heart Failure

Interventions

PROCEDURE

Harvesting and Implantation of Adipose-Derived Stem Cells (ASCs)

Local liposuction procedure to harvest the fat tissue. Adipose Derived Stem Cells are then implanted via intramyocardial and intravenous injection.

Sponsors & Collaborators

  • Instituto de Medicina Regenerativa

    collaborator INDUSTRY

  • Ageless Regenerative Institute

    lead INDUSTRY

Principal Investigators

  • Juan J Parcero, MD · Instituto de Medicina Regenerativa

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2014-12-31
Completion
2015-06-30

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01502501 on ClinicalTrials.gov